ARCHIVES

NCI Sends A Second Letter To Groups About Carboplatin

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982